Artículos por temáticas

Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study

Gauthier S, Robillard A, Cohen S, Black S, Sampalis J, Colizza D, de Takacsy F, Schecter R; EMBRACE investigators.

Curr Med Res Opin. 2013 Aug;29(8):989-1000. doi: 10.1185/03007995.2013.802230. Epub 2013 May 23.

The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's disease

Lewis JE, McDaniel HR, Agronin ME, Loewenstein DA, Riveros J, Mestre R, Martinez M, Colina N, Abreu D, Konefal J, Woolger JM, Ali KH.

J Alzheimers Dis. 2013;33(2):393-406. doi: 10.3233/JAD-2012-121381.

Concentration of donepezil to the cognitive response in Alzheimer disease

Yang YH, Chen CH, Chou MC, Li CH, Liu CK, Chen SH.

J Clin Psychopharmacol. 2013 Jun;33(3):351-5. doi: 10.1097/JCP.0b013e31828b5087.

Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial

Pitkälä KH, Pöysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE.

JAMA Intern Med. 2013 May 27;173(10):894-901. doi: 10.1001/jamainternmed.2013.359.

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease

Rive B, Gauthier S, Costello S, Marre C, François C.

CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x.

Liver X receptors: emerging therapeutic targets for Alzheimer's disease

Sodhi RK, Singh N.

Pharmacol Res. 2013 Jun;72:45-51. doi: 10.1016/j.phrs.2013.03.008. Epub 2013 Mar 28.

Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease

Leclerc B, Abulrob A.

ScientificWorldJournal. 2013;2013:589308. doi: 10.1155/2013/589308. Epub 2013 Feb 5.

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

Yang G, Wang Y, Tian J, Liu JP.

PLoS One. 2013 Sep 23;8(9):e74916. doi: 10.1371/journal.pone.0074916. eCollection 2013.

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

McGeer PL, McGeer EG.

Acta Neuropathol. 2013 Oct;126(4):479-97. doi: 10.1007/s00401-013-1177-7. Epub 2013 Sep 20.

Effectiveness and safety of memantine treatment for Alzheimer's disease

Yang Z, Zhou X, Zhang Q.

J Alzheimers Dis. 2013;36(3):445-58. doi: 10.3233/JAD-130395.

Effects of ramelteon on refractory behavioral and psychological symptoms of dementia in Alzheimer disease

Asano M, Ishitobi M, Tanaka Y, Wada Y.

J Clin Psychopharmacol. 2013 Aug;33(4):579-81. doi: 10.1097/JCP.0b013e3182946702.

New approaches to the treatment of Alzheimer's disease

Rampa A, Bisi A.

Curr Top Med Chem. 2013;13(15):1743-4. doi: 10.2174/15680266113139990134.

Dance with me

Aka S.

Can Nurse. 2013 Oct;109(8):30-1.

Clinical trials in predementia stages of Alzheimer disease

Pillai JA, Cummings JL.

Med Clin North Am. 2013 May;97(3):439-57. doi: 10.1016/j.mcna.2013.01.002. Epub 2013 Feb 22.

Immunotherapy for targeting tau pathology in Alzheimer's disease and tauopathies

Rosenmann H.

Curr Alzheimer Res. 2013 Mar;10(3):217-28. doi: 10.2174/1567205011310030001.